Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000711377-18-000004
Filing Date
2018-02-21
Accepted
2018-02-21 21:13:59
Documents
1
Period of Report
2018-02-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4434
  Complete submission text file 0000711377-18-000004.txt   5632
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address
BRADLEY EDWARD (Reporting) CIK: 0001189021 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17988 | Film No.: 18630412